Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington, DC 20001
P: 202.249.7100
E: [email protected]
Dr. Navayath Shobana serves as Head of Regulatory Affairs Leads at Fresenius Kabi. She has more than a decade of experience in the biosimilar area. In her current role, she has been instrumental in advancing the company’s biosimilar portfolio and getting approvals for several biosimilars. She leads a global team that is responsible for regulatory strategy, interaction with global health authorities and policy advocacy. Deeply passionate about biosimilars and expanding access to affordable medicines, Dr. Shobana is committed to improving patient care worldwide.